Marilynn Larkin

August 11, 2026 Eleven percent of US adults currently take GLP-1s for weight loss, up significantly from 3% in 2024, according to a new

The Quebec government says it has given primary care access to more than 500,000 patients who don’t have a family doctor, but most still don’t have one.

Daily consumption of tomatoes and tomato sauce seems to reduce hepatic steatosis in adults with MASLD.

Gelatin can promote a feeling of fullness, but it’s unlikely to result in weight loss over the long term.

A new joint global statement says that exercise physiologists should be part of a multidisciplinary obesity care team for patients taking weight management medications.

August 26, 2026 Patients who use gray-market retatrutide seemed to achieve roughly half the expected weight-loss benefit relative to Eli

Two studies challenge conventional weight-loss advice.

August 28, 2026 CMAJ. 2026;198(29):E1143-E1152. doi:10.1503/cmaj.250123

Eli Lilly's Mounjaro ( tirzepatide ) is now FDA-approved to reduce cardiovascular risk in adults with type 2 diabetes (T2D).

Lilly's Mounjaro (tirzepatide) is now approved to reduce cardiovascular risk in adults with type 2 diabetes.